Rare nephrology
Kidney diseases and post-transplant complications can deeply affect your health and quality of life.1 Alexion’s nephrology research focuses on protecting organ function, preventing transplant rejection, and improving long-term outcomes for people facing rare kidney conditions.
Recruiting trials
Nephrology
Study of Ravulizumab in Pediatric Participants With Primary IgAN (ICAN Jr.)
More informationNephrology
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) (AUTUMN)
More informationNephrology
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation (AWAKE)
More information
Turning research into real impact
Alexion aims to redefine what’s possible in kidney medicine through innovative, patient-centered research.
-
Understanding immune-related kidney disease
We’re exploring how immune system responses contribute to rare kidney disease and transplant complications.
-
Preventing organ rejection
Our studies aim to help the body better accept transplants while maintaining overall health.
-
Improving lifelong outcomes
We’re committed to supporting patients beyond treatment – improving function, recovery, and confidence as you return to daily life.
References
- mayoclinic.org/diseases-conditions/chronic-kidney-disease/symptoms-causes/syc-20354521
